249 related articles for article (PubMed ID: 2937177)
1. HLA-DP related suppression of mixed lymphocyte reaction with alloactivated lymphocytes.
Odum N; Hofmann B; Jakobsen BK; Langhoff E; Morling N; Platz P; Ryder LP; Svejgaard A
Tissue Antigens; 1986 Jan; 27(1):32-43. PubMed ID: 2937177
[TBL] [Abstract][Full Text] [Related]
2. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
4. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
[TBL] [Abstract][Full Text] [Related]
5. The role of differential class II antigen expression in stimulation of allogeneic mixed lymphocyte reactions by human monocyte hybridomas.
Shaked A; Hoyos B; Mayer L
Transplantation; 1992 Jun; 53(6):1341-7. PubMed ID: 1534941
[TBL] [Abstract][Full Text] [Related]
6. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
7. HLA-DP incompatibilities induce significant proliferation in primary mixed lymphocyte cultures in HLA-A, -B, -DR and -DQ compatible individuals: implications for allogeneic bone marrow transplantation.
Olerup O; Möller E; Persson U
Tissue Antigens; 1990 Nov; 36(5):194-202. PubMed ID: 1982746
[TBL] [Abstract][Full Text] [Related]
8. An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2B.
Odum N; Hartzman R; Jakobsen BK; Morling N; Platz P; Robbins FM; Ryder LP; Shaw S; Svejgaard A
Tissue Antigens; 1986 Jan; 27(1):44-52. PubMed ID: 3082036
[TBL] [Abstract][Full Text] [Related]
9. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
Walsh LJ; Seymour GJ; Powell RN
J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP.
Strassmann G; Ress S; Anichini A; Bach FH
Hum Immunol; 1985 Jun; 13(2):125-37. PubMed ID: 3874193
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of HLA class I and class II antigen loss mutants reveals a homozygous deletion of the DR, DQ, and part of the DP region: implications for class II gene order.
Erlich H; Lee JS; Petersen JW; Bugawan T; DeMars R
Hum Immunol; 1986 Jun; 16(2):205-19. PubMed ID: 3459724
[TBL] [Abstract][Full Text] [Related]
14. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
15. Alloactivated long-term cultured human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity.
Pawelec G; Blaurock M; Schneider EM; Shaw S; Wernet P
Eur J Immunol; 1982 Nov; 12(11):967-72. PubMed ID: 6983971
[TBL] [Abstract][Full Text] [Related]
16. AMLR and MLR stimulating activity of human T lymphocytes activated in vitro by soluble HLA-DR antigens.
Vanoli M; Scorza Smeraldi R; Fabio G; Bonara P; Sabbadini MG; Zanussi C
Clin Exp Immunol; 1986 Jan; 63(1):163-70. PubMed ID: 2420496
[TBL] [Abstract][Full Text] [Related]
17. Specific suppression of mixed lymphocyte reactions by alloactivated cells is correlated with cytotoxicity.
Vandekerckhove BA; Timmermans-de Jong EJ; Termijtelen A; Claas FH
Hum Immunol; 1989 Mar; 24(3):183-94. PubMed ID: 2522427
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
20. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
